We are live on ! Find out more
PFE icon

Pfizer
PFE

Fund managers haven’t disclosed any holdings of PFE yet.

PFE Hedge Fund Activity: Q2 2026 in Review

2,818 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q2 2026, worth a combined $91.7B — down 13% from $106B a quarter earlier.

Sellers outnumbered buyers: 234 funds closed out of PFE and 154 opened new positions — a net loss of 80 holders — while 1,207 trimmed existing stakes and 1,159 added.

The largest buyer was BlackRock, adding an estimated $822M. The largest seller was Wellington Management Group, cutting an estimated $578M.

  • 2,818 institutional investors held Pfizer (PFE) as of Q2 2026, down from 2,952 in Q1 2026.
  • Funds reported $91.7B of Pfizer stock for Q2 2026, down 13% quarter-over-quarter.
  • 154 funds opened new Pfizer positions in Q2 2026 and 234 closed out, a net change of -80 holders.
  • The largest Pfizer buyer in Q2 2026 was BlackRock, an estimated $822M added.
  • The largest Pfizer seller in Q2 2026 was Wellington Management Group, an estimated $578M sold.

Based on aggregated 13F filings for Q2 2026.